FBI Approves Thermo Fisher Scientific Forensic Sequencing Solution for National DNA Index System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN FRANCISCO, July 9, 2019 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems Precision ID System mtDNA analysis solution for use by forensic laboratories to generate mitochondrial DNA (mtDNA) profiles for submission to the U.S. National DNA Index System (NDIS) CODIS database. The use of mtDNA in forensics over the past several decades has played a pivotal role in helping to solve missing person cases and identification of remains recovered from mass disasters.

Due to its high copy number per cell, mtDNA is the primary testing method for forensic laboratories that routinely analyze extremely challenging samples, such as decades-old bone fragments, teeth and other human remains. While the methodology has proven useful to help close missing person cases, for example, profiles derived from next-generation sequencing (NGS)-based platforms could not be uploaded to the national database until recently. Approval of the panel now provides laboratories with the ability to analyze the most challenging missing persons and criminal casework samples while providing the greatest level of discrimination through whole mtDNA genome analysis.

The Precision ID mtDNA Whole Genome Panel is part of a NGS-based system that includes the Ion GeneStudio S5 System, the Ion Chef System for automated library and template generation, as well as forensically relevant Precision ID panels for mtDNA analysis. The Precision ID mtDNA panels give forensic DNA laboratories the ability to detect variation within noncoding control region sequences using as little as 2 pg of DNA.

The end to end solution also includes the Applied Biosystems Converge Software NGS Data Analysis module, which automates mitochondrial DNA analysis by leveraging optimized base calling, phylogenetically guided alignment and quality filtering algorithms. 

“The Precision ID System for mtDNA analysis offers excellent sensitivity for both sample quality and quantity,” said Rosy Lee, vice president and general manager of Human Identification for Thermo Fisher Scientific. “Traditional methods for mtDNA analysis can be time-consuming and expensive. With the NDIS approval of Precision ID System, forensic scientists can now maximize the potential of this forensic genetic marker.”

Learn more at www.thermofisher.com/hid-ngs

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Media Contact
Mauricio Minotta
Director, Public Relations
+1 760 929 2456
Mauricio.minotta@thermofisher.com

View original content:http://www.prnewswire.com/news-releases/fbi-approves-thermo-fisher-scientific-forensic-sequencing-solution-for-national-dna-index-system-300881419.html

SOURCE Thermo Fisher Scientific

Staff

Recent Posts

CoVet Expands Clinical Leadership with Launch of In-House Medical Department

Veterinary AI leader CoVet introduces a dedicated Medical Department to ensure clinical accuracy, real-world relevance,…

4 hours ago

New ASTHO Legal Map Illuminates State and Territorial Suicide Prevention Infrastructure

ARLINGTON, Va., July 24, 2025 /PRNewswire/ -- The Association of State and Territorial Health Officials…

4 hours ago

Loomis expands its Pharma business by acquiring Kipfer-Logistik

STOCKHOLM, Sweden, July 24, 2025 /PRNewswire/ -- Loomis AB has, through its subsidiary Loomis International…

4 hours ago

HealthArc and PatchRx Partner to Boost Medication Adherence in Pain Management

Integrated RTM solution to deliver real-time medication adherence insights for pain and mental health practices.…

4 hours ago

Loopback Analytics Welcomes Industry Leader Elizabeth Cherry as Vice President of Access Solutions

DALLAS, July 24, 2025 /PRNewswire/ -- Loopback Analytics is excited to welcome Elizabeth Cherry, PharmD,…

4 hours ago

123Invent Inventor Develops Modified Glasses to Assist with Reading (BRA-8028)

PITTSBURGH , July 24, 2025 /PRNewswire/ -- "I wanted to create reading glasses like to no…

4 hours ago